21MedTech LLC

Durham, NC · Medtech · Private

Antibiotic-loaded bioresorbable polymer envelope for implantable cardiovascular devices with controlled drug release

Grants
$3.7M
3 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Health and Human Services · Phase II · Non-Opioid Post-Operative Pain Management Using Bupivacaine-loaded Poly(ester urea) Mesh$1,730,751
Federal grantDepartment of Health and Human Services · Phase II · ARRAY: A novel polymeric mesh for prophylactic antibiotic protection of cardiac implantable electronic devices$999,978
Federal grantDepartment of Health and Human Services · Phase II · ARRAY: A novel polymeric mesh for prophylactic antibiotic protection of cardiac implantable electronic devices$992,480
Federal grant · SBIR/STTR

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2067ACETAMINOPHEN TOXICITY DIAGNOSTICS, LLC——
2068BIOPEPTIDES CORP——
2069E-Lambda LLC——
207021MedTech LLC——
2071VIZMA LIFE SCIENCES INC——
2072Double Helix Optics Inc——
2073DURAMETRIX LLC——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.